BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Esser N, Zraika S. Neprilysin Inhibitors and Angiotensin(1-7) in COVID-19. Br J Cardiol 2020;27:109-11. [PMID: 33795925 DOI: 10.5837/bjc.2020.031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Yamamoto K, Rakugi H. Angiotensin receptor-neprilysin inhibitors: Comprehensive review and implications in hypertension treatment. Hypertens Res 2021. [PMID: 34290389 DOI: 10.1038/s41440-021-00706-1] [Reference Citation Analysis]
2 Esser N, Schmidt C, Barrow BM, Cronic L, Hackney DJ, Mongovin SM, Hogan MF, Templin AT, Castillo JJ, Hull RL, Zraika S. Insulinotropic Effects of Neprilysin and/or Angiotensin Receptor Inhibition in Mice. Front Endocrinol 2022;13:888867. [DOI: 10.3389/fendo.2022.888867] [Reference Citation Analysis]